-
Mashup Score: 1Comprehensive molecular testing in lung cancer ‘absolutely crucial’ yet underutilized - 9 month(s) ago
Precision medicine has shown great potential to improve treatment outcomes and prolong survival of patients with lung cancer, as biomarker-driven therapies continue to extend their reach in this space.According to International Association for the Study of Lung Cancer, more than half of patients with lung cancer have tumors that harbor potentially actionable driver mutations. Therapies targeting
Source: www.healio.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group - 10 month(s) ago
Next-generation sequencing (NGS) diagnostics have shown clinical utility in predicting survival benefits in patients with certain cancer types who are…
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists2Tweet-
📢 The @apoddc team is excited to share with you our #inaugural publication! A true #multinational effort in establishing use & #recommendations of #NGS in #Asia in advanced cancers taking account of #epidemiology and #accessibility. @ESMO_Open @OncoAlert https://t.co/bCa8sDG9IP https://t.co/pl7uAjPpAC
-
-
Mashup Score: 0Thermo Fisher, Pfizer partner to boost NGS cancer testing outside U.S. - 12 month(s) ago
The agreement is expected to increase access to next-generation sequencing for patients in more than 30 countries.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@ThermoFisher @Pfizer partner to boost #NGS #cancer testing outside #US | #diagnostics https://t.co/MPsBsSbuRN
-
-
Mashup Score: 0Leveraging NGS-Tech in Healthcare Applications - 12 month(s) ago
Leveraging NGS-Tech in Healthcare Applications
Source: www.biospectrumindia.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
#India Leveraging #NGS-Tech in #Healthcare Applications | #opinion https://t.co/th2UW54qwS
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A new study accessing an integrated next-generation sequencing system reports promising results in delivering accurate genomics-based diagnoses of #myeloidneoplasms in less than 24 hours: https://t.co/6aXqino1vf #NGS #Genomics https://t.co/3vjC3JtRrj
-
-
Mashup Score: 0
Genome Insight will develop whole genome bioinformatics for Ultima’s sequencing instrument platform under the agreement.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Genomics companies @UltimaGenomics & Genome Insight partner to offer low-cost sequencing #NGS for #cancer patients | #diagnostics https://t.co/4Gb8liR4ed
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A new study accessing an integrated next-generation sequencing system reports promising results in delivering accurate genomics-based diagnoses of #myeloidneoplasms in less than 24 hours: https://t.co/6aXqino1vf #NGS #Genomics https://t.co/zUusgkxS0u
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A new study accessing an integrated next-generation sequencing system reports promising results in delivering accurate genomics-based diagnoses of #myeloidneoplasms in less than 24 hours: https://t.co/6aXqino1vf #NGS #Genomics https://t.co/6s8y9pU3CW
-
-
Mashup Score: 13Post-azacitidine clone size predicts outcome of patients with myelodysplastic syndromes and related myeloid neoplasms - 1 year(s) ago
Key Points. Major clone sizes in post-treatment samples are strongly correlated with clinical response.Inclusion of post-treatment clone size into the prognosti
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
We are long overdue for incorporation of genomics into response criteria for #MDS 👇🏻fantastic work providing evidence that payors must reimburse #NGS on post tx BM in MDS which is not the case (at least consistently) now. #hemepath #MDSsm #leusm https://t.co/giPDoTLNu9
-
-
Mashup Score: 0Illumina launches cloud-based next-gen sequencing software - 1 year(s) ago
Illumina announced today that it released its Connected Insights cloud-based software for next-generation sequencing (NGS).
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@illumina launches #cloud-based #nextgen sequencing software | #NGS #diagnostics https://t.co/1veEnRYwL3
-
In summary, every patient with advanced #NSCLC should undergo #ComprehensiveMolecularGenotyping with broad panel #NGS to ensure delivery of appropriate therapy! https://t.co/7ozABwtYWc https://t.co/wZWfHDVqep